Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Dec;9(6):449-59.
doi: 10.1007/s11920-007-0061-3.

The STAR*D Project Results: A Comprehensive Review of Findings

Affiliations
Randomized Controlled Trial

The STAR*D Project Results: A Comprehensive Review of Findings

Diane Warden et al. Curr Psychiatry Rep. .

Abstract

The Sequenced Treatment Alternatives to Relieve Depression trial enrolled outpatients with nonpsychotic major depressive disorder treated prospectively in a series of randomized controlled trials. These were conducted in representative primary and psychiatric practices. Remission rates for treatment steps 1 to 4 based on the 16-item Quick Inventory of Depressive Symptomatology-Self-report were 37%, 31%, 14%, and 13%, respectively. There were no differences in remission rates or times to remission among medication switch or among medication augmentation strategies at any treatment level. Participants who required increasing numbers of treatment steps showed greater depressive illness burden and increasingly greater relapse rates in the naturalistic follow-up period (40%-71%). Prognosis was better at all levels for participants who entered follow-up in remission as opposed to those who entered with response without remission. These results highlight the prevalence of treatment-resistant depression and suggest potential benefit for using more vigorous treatments in the earlier steps.

Similar articles

See all similar articles

Cited by 118 articles

See all "Cited by" articles

References

    1. J Gen Intern Med. 1995 Dec;10(12):663-70 - PubMed
    1. Am J Psychiatry. 2006 Jan;163(1):28-40 - PubMed
    1. Neuropsychopharmacology. 2007 Dec;32(12):2479-89 - PubMed
    1. BMJ. 2002 Oct 26;325(7370):934 - PubMed
    1. JAMA. 2003 Jun 18;289(23):3095-105 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Feedback